Research graph
References from Digging deeper, not digging in: can adversarial collaboration bring us closer to optimal antibiotic decisions in sepsis?. Local targets link to admitted publications; unresolved targets remain external evidence.
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
10.1097/ccm.0000000000007075 · 2026 · External reference
Cefepime-induced neurotoxicity: a systematic review
10.1186/s13054-017-1856-1 · 2017 · External reference
Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit
10.1016/j.jcrc.2018.08.007 · 2018 · External reference
Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: the ACORN randomized clinical trial
10.1001/jama.2023.20583 · 2023 · External reference
Mortality of patients with sepsis administered piperacillin-tazobactam vs cefepime
10.1001/jamainternmed.2024.0581 · 2024 · External reference
Nut cracked? Does the ACORN trial end the debate surrounding vancomycin and piperacillin-tazobactam combination therapy and increased risk for acute kidney injury?
10.1093/ofid/ofad645 · 2024 · External reference
Does piperacillin-tazobactam increase mortality risk compared with cefepime? Collider bias and the importance of assumptions in instrumental variable analyses
10.1093/cid/ciaf317 · 2026 · External reference
10.1093/ajrccm/aamag257 · 2026 · Admitted local publication
Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1/PD-L1 pathway
10.3389/fimmu.2020.624279 · 2020 · External reference
Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial
10.1001/jama.2025.24175 · 2026 · External reference
From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU
10.1164/rccm.202311-2086so · 2024 · External reference
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials
10.1016/s2213-2600(23)00237-0 · 2023 · External reference
Make science more collegial: why the time for ‘adversarial collaboration’ has come
10.1038/d41586-025-01379-3 · 2025 · External reference
Unresolved reference
External reference
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill
10.1016/s2213-2600(25)00054-2 · 2025 · External reference
